Fred Aslan Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 days, 15 hours ago
Fred Aslan has an estimated net worth of at least $16.8 million*, as of May 13, 2026. They own 1.5 million shares of ARTV stock. They have sold 87,678 shares of ARTV stock since 2021, for an estimated $263,223.
Fred Aslan $ARTV SEC Form 4 Insider Trading
Fred Aslan has filed a total of 5 insider trades in $ARTV since 2021. Their most recent trade was a sale of 27,116 shares, made on May 19, 2026. Their largest trade was a sale of 27,116 shares, made on May 19, 2026. We estimate that they now own 1.5 million shares of $ARTV, worth an estimated $16.5 million.
Insider Trading at $ARTV
There have been a total of 18 insider trades reported at $ARTV since 2021, with 20.3 million shares purchased and 113,602 shares sold. The most active insider traders in $ARTV stock have been Fred Aslan, Christopher Horan, and Fred Aslan. The most recent trade was a sale of 3,095 shares reported by Heather Raymon (SVP, Research and Development), made on May 19, 2026.
History of Insider Stock Trades by Fred Aslan
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ARTV
|
Sale | 27,116 | May 19, 2026 | May 19, 2026, 9:50 p.m. |
ARTV
|
Sale | 3,187 | Dec 15, 2025 | Dec. 15, 2025, 10:19 p.m. |
ARTV
|
Sale | 6,375 | Nov 17, 2025 | Nov. 17, 2025, 9:37 p.m. |
ARTV
|
Sale | 25,500 | Oct 17, 2025 | Oct. 17, 2025, 8:44 p.m. |
ARTV
|
Sale | 25,500 | Aug 15, 2025 | Aug. 18, 2025, 8:15 p.m. |
$ARTV Executives and Stock Owners with Insider Trades
-
Fred Aslan, President and CEO
-
Christopher Horan, Chief Tech Operations Officer
-
Fred Aslan, Chief Executive Officer
-
Heather Raymon, SVP, Research and Development
-
Jennifer Bush, COO, CLO, Compliance Officer
-
Subhashis Banerjee, Chief Medical Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.